Media Summary: The human body has both innate and adaptive body defence. Dr. Manu Jain shares about the three approaches researchers are using that could take us closer than ever to a cure. These Presenter: Mandy L. Ford, PhD Professor, Department of Surgery Scientific Director Emory Transplant Center Learning objectives: ...

Assembly Modulation A New Drug - Detailed Analysis & Overview

The human body has both innate and adaptive body defence. Dr. Manu Jain shares about the three approaches researchers are using that could take us closer than ever to a cure. These Presenter: Mandy L. Ford, PhD Professor, Department of Surgery Scientific Director Emory Transplant Center Learning objectives: ... A simple explanation by Marom Bikson on what make neuromodulation device work, what makes the special, so how to design a ... In this Assay Guidance Manual Webinar from August 27, 2025, Dr. Raymond Deshaies discusses the past, present, and future ... Since the FDA initiated Project Optimus, considerable effort has been stimulated to better select doses of

This lecture provides a simple and comprehensive overview of what Neuromodulation Design is. How are neuromodulation ... An overview of Antisense Oligonucleotides (ASOs) and how they're used to treat certain genetic diseases. Version that includes ... This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ... On May 27, 2026, the Reagan-Udall Foundation for the FDA, in collaboration with ARPA-H and XPRIZE Foundation, convened a ... Amina Becic PhD Title: Investigations on the

Photo Gallery

Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases
Drugs for Immune System Modulation
New Developments in Disease-Modifying Drugs
2-Minute Neuroscience: Agonism, Antagonism, & Allosteric Modulation
The Road to Transplantation Tolerance via Pharmacologic Modulation of Immunity
How to Invent a Neuromodulation Device (in 3 steps)
Raymond Deshaies: How Proximity-Based Drugs Are Redefining Pharmacotherapy
Project Optimus: Oncology Dose Optimization Based on Clinical Pharmacology Strategy & MIDD Approach
Neuromodulation Design and Biomarkers (Dr. Marom Bikson)
Fixing Genes with Antisense Oligonucleotides (ASOs)
AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation
Regulatory Constructs for Gerotherapeutic Drug, Biologic & Device Development: Afternoon Session
View Detailed Profile
Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases

Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases

Most central nervous system

Drugs for Immune System Modulation

Drugs for Immune System Modulation

The human body has both innate and adaptive body defence.

New Developments in Disease-Modifying Drugs

New Developments in Disease-Modifying Drugs

Dr. Manu Jain shares about the three approaches researchers are using that could take us closer than ever to a cure. These

2-Minute Neuroscience: Agonism, Antagonism, & Allosteric Modulation

2-Minute Neuroscience: Agonism, Antagonism, & Allosteric Modulation

Drugs

The Road to Transplantation Tolerance via Pharmacologic Modulation of Immunity

The Road to Transplantation Tolerance via Pharmacologic Modulation of Immunity

Presenter: Mandy L. Ford, PhD Professor, Department of Surgery Scientific Director Emory Transplant Center Learning objectives: ...

How to Invent a Neuromodulation Device (in 3 steps)

How to Invent a Neuromodulation Device (in 3 steps)

A simple explanation by Marom Bikson on what make neuromodulation device work, what makes the special, so how to design a ...

Raymond Deshaies: How Proximity-Based Drugs Are Redefining Pharmacotherapy

Raymond Deshaies: How Proximity-Based Drugs Are Redefining Pharmacotherapy

In this Assay Guidance Manual Webinar from August 27, 2025, Dr. Raymond Deshaies discusses the past, present, and future ...

Project Optimus: Oncology Dose Optimization Based on Clinical Pharmacology Strategy & MIDD Approach

Project Optimus: Oncology Dose Optimization Based on Clinical Pharmacology Strategy & MIDD Approach

Since the FDA initiated Project Optimus, considerable effort has been stimulated to better select doses of

Neuromodulation Design and Biomarkers (Dr. Marom Bikson)

Neuromodulation Design and Biomarkers (Dr. Marom Bikson)

This lecture provides a simple and comprehensive overview of what Neuromodulation Design is. How are neuromodulation ...

Fixing Genes with Antisense Oligonucleotides (ASOs)

Fixing Genes with Antisense Oligonucleotides (ASOs)

An overview of Antisense Oligonucleotides (ASOs) and how they're used to treat certain genetic diseases. Version that includes ...

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ...

Regulatory Constructs for Gerotherapeutic Drug, Biologic & Device Development: Afternoon Session

Regulatory Constructs for Gerotherapeutic Drug, Biologic & Device Development: Afternoon Session

On May 27, 2026, the Reagan-Udall Foundation for the FDA, in collaboration with ARPA-H and XPRIZE Foundation, convened a ...

5-Bećić Amina, "Assembly, function and modulation of Plant Glutamate Receptor Homologues"

5-Bećić Amina, "Assembly, function and modulation of Plant Glutamate Receptor Homologues"

Amina Becic PhD Title: Investigations on the